America September 8, 2026
MFN Drugmakers Cross-Border Pricing Upends Licensing Deals Under Trump Plan
A Trump administration program designed to slash U.S. prescription drug prices is sending shock waves through the pharmaceutical industry, where…
America September 8, 2026
A Trump administration program designed to slash U.S. prescription drug prices is sending shock waves through the pharmaceutical industry, where…
By Rihem Akkouche

